Integrating Procurement, Production Planning, and Inventory Management Processes through Negotiation Information

G. Confessore,Silvia Rismondo,G. Stecca

DOI: https://doi.org/10.1007/1-4020-8139-1_26

2004-08-22

Abstract:

What problem does this paper attempt to address?

Inhibition mechanisms of CRISPR-Cas9 by AcrIIA25.1 and AcrIIA32

DOI: https://doi.org/10.1007/s11427-024-2607-8

2024-06-07

Science China Life Sciences

Abstract:In the ongoing arms race between bacteria and bacteriophages, bacteriophages have evolved anti-CRISPR proteins to counteract bacterial CRISPR-Cas systems. Recently, AcrIIA25.1 and AcrIIA32 have been found to effectively inhibit the activity of SpyCas9 both in bacterial and human cells. However, their molecular mechanisms remain elusive. Here, we report the cryo-electron microscopy structures of ternary complexes formed by AcrIIA25.1 and AcrIIA32 bound to SpyCas9-sgRNA. Using structural analysis and biochemical experiments, we revealed that AcrIIA25.1 and AcrIIA32 recognize a novel, previously-unidentified anti-CRISPR binding site on SpyCas9. We found that both AcrIIA25.1 and AcrIIA32 directly interact with the WED domain, where they spatially obstruct conformational changes of the WED and PI domains, thereby inhibiting SpyCas9 from recognizing protospacer adjacent motif (PAM) and unwinding double-stranded DNA. In addition, they may inhibit nuclease activity by blocking the dynamic conformational changes of the SpyCas9 surveillance complex. In summary, our data elucidate the inhibition mechanisms of two new anti-CRISPR proteins, provide new strategies for the modulation of SpyCas9 activity, and expand our understanding of the diversity of anti-CRISPR protein inhibition mechanisms.

biology
Disabling Cas9 by an anti-CRISPR DNA mimic

Jiyung Shin,Fuguo Jiang,Jun-Jie Liu,Nicolas L Bray,Benjamin J Rauch,Seung Hyun Baik,Eva Nogales,Joseph Bondy-Denomy,Jacob E Corn,Jennifer A Doudna

DOI: https://doi.org/10.1126/sciadv.1701620

2017-07-12

Abstract:CRISPR (clustered regularly interspaced short palindromic repeats)-Cas9 gene editing technology is derived from a microbial adaptive immune system, where bacteriophages are often the intended target. Natural inhibitors of CRISPR-Cas9 enable phages to evade immunity and show promise in controlling Cas9-mediated gene editing in human cells. However, the mechanism of CRISPR-Cas9 inhibition is not known, and the potential applications for Cas9 inhibitor proteins in mammalian cells have not been fully established. We show that the anti-CRISPR protein AcrIIA4 binds only to assembled Cas9-single-guide RNA (sgRNA) complexes and not to Cas9 protein alone. A 3.9 Å resolution cryo-electron microscopy structure of the Cas9-sgRNA-AcrIIA4 complex revealed that the surface of AcrIIA4 is highly acidic and binds with a 1:1 stoichiometry to a region of Cas9 that normally engages the DNA protospacer adjacent motif. Consistent with this binding mode, order-of-addition experiments showed that AcrIIA4 interferes with DNA recognition but has no effect on preformed Cas9-sgRNA-DNA complexes. Timed delivery of AcrIIA4 into human cells as either protein or expression plasmid allows on-target Cas9-mediated gene editing while reducing off-target edits. These results provide a mechanistic understanding of AcrIIA4 function and demonstrate that inhibitors can modulate the extent and outcomes of Cas9-mediated gene editing.
Anti-CRISPR AcrIIC5 is a dsDNA mimic that inhibits type II-C Cas9 effectors by blocking PAM recognition

Wei Sun,Xiaolong Zhao,Jinlong Wang,Xiaoqi Yang,Zhi Cheng,Shuo Liu,Jiuyu Wang,Gang Sheng,Yanli Wang

DOI: https://doi.org/10.1093/nar/gkad052

IF: 14.9

2023-02-08

Nucleic Acids Research

Abstract:Anti-CRISPR proteins are encoded by phages to inhibit the CRISPR-Cas systems of the hosts. AcrIIC5 inhibits several naturally high-fidelity type II-C Cas9 enzymes, including orthologs from Neisseria meningitidis (Nme1Cas9) and Simonsiella muelleri (SmuCas9). Here, we solve the structure of AcrIIC5 in complex with Nme1Cas9 and sgRNA. We show that AcrIIC5 adopts a novel fold to mimic the size and charge distribution of double-stranded DNA, and uses its negatively charged grooves to bind and occlude the protospacer adjacent motif (PAM) binding site in the target DNA cleft of Cas9. AcrIIC5 is positioned into the crevice between the WED and PI domains of Cas9, and one end of the anti-CRISPR interacts with the phosphate lock loop and a linker between the RuvC and BH domains. We employ biochemical and mutational analyses to build a model for AcrIIC5's mechanism of action, and identify residues on both the anti-CRISPR and Cas9 that are important for their interaction and inhibition. Together, the structure and mechanism of AcrIIC5 reveal convergent evolution among disparate anti-CRISPR proteins that use a DNA-mimic strategy to inhibit diverse CRISPR-Cas surveillance complexes, and provide new insights into a tool for potent inhibition of type II-C Cas9 orthologs.

biochemistry & molecular biology
Structural and Mechanistic Insight into CRISPR-Cas9 Inhibition by Anti-CRISPR Protein AcrIIC4Hpa

Sungwon Hwang,Chuxi Pan,Bianca Garcia,Alan R Davidson,Trevor F Moraes,Karen L Maxwell

DOI: https://doi.org/10.1016/j.jmb.2021.167420

2022-03-15

Abstract:Phages, plasmids, and other mobile genetic elements express inhibitors of CRISPR-Cas immune systems, known as anti-CRISPR proteins, to protect themselves from targeted destruction. These anti-CRISPR proteins have been shown to function through very diverse mechanisms. In this work we investigate the activity of an anti-CRISPR isolated from a prophage in Haemophilus parainfluenzae that blocks CRISPR-Cas9 DNA cleavage activity. We determine the three-dimensional crystal structure of AcrIIC4Hpa and show that it binds to the Cas9 Recognition Domain. This binding does not prevent the Cas9-anti-CRISPR complex from interacting with target DNA but does inhibit DNA cleavage. AcrIIC4Hpa likely acts by blocking the conformational changes that allow the HNH and RuvC endonuclease domains to contact the DNA sites to be nicked.
Inhibitory mechanism of CRISPR-Cas9 by AcrIIC4

Xuzichao Li,Fumeng Liao,Jiaqi Gao,Guangyong Song,Chendi Zhang,Nan Ji,Xiaoshen Wang,Jing Wen,Jia He,Yong Wei,Heng Zhang,Zhuang Li,Guimei Yu,Hang Yin

DOI: https://doi.org/10.1093/nar/gkad669

IF: 14.9

2023-08-18

Nucleic Acids Research

Abstract:CRISPR-Cas systems act as the adaptive immune systems of bacteria and archaea, targeting and destroying invading foreign mobile genetic elements (MGEs) such as phages. MGEs have also evolved anti-CRISPR (Acr) proteins to inactivate the CRISPR-Cas systems. Recently, AcrIIC4, identified from Haemophilus parainfluenzae phage, has been reported to inhibit the endonuclease activity of Cas9 from Neisseria meningitidis (NmeCas9), but the inhibition mechanism is not clear. Here, we biochemically and structurally investigated the anti-CRISPR activity of AcrIIC4. AcrIIC4 folds into a helix bundle composed of three helices, which associates with the REC lobe of NmeCas9 and sgRNA. The REC2 domain of NmeCas9 is locked by AcrIIC4, perturbing the conformational dynamics required for the target DNA binding and cleavage. Furthermore, mutation of the key residues in the AcrIIC4-NmeCas9 and AcrIIC4-sgRNA interfaces largely abolishes the inhibitory effects of AcrIIC4. Our study offers new insights into the mechanism of AcrIIC4-mediated suppression of NmeCas9 and provides guidelines for the design of regulatory tools for Cas9-based gene editing applications.

biochemistry & molecular biology
Inhibition of CRISPR-Cas9 ribonucleoprotein complex assembly by anti-CRISPR AcrIIC2

Annoj Thavalingam,Zhi Cheng,Bianca Garcia,Xue Huang,Megha Shah,Wei Sun,Min Wang,Lucas Harrington,Sungwon Hwang,Yurima Hidalgo-Reyes,Erik J Sontheimer,Jennifer Doudna,Alan R Davidson,Trevor F Moraes,Yanli Wang,Karen L Maxwell

DOI: https://doi.org/10.1038/s41467-019-10577-3

2019-06-26

Abstract:CRISPR-Cas adaptive immune systems function to protect bacteria from invasion by foreign genetic elements. The CRISPR-Cas9 system has been widely adopted as a powerful genome-editing tool, and phage-encoded inhibitors, known as anti-CRISPRs, offer a means of regulating its activity. Here, we report the crystal structures of anti-CRISPR protein AcrIIC2Nme alone and in complex with Nme1Cas9. We demonstrate that AcrIIC2Nme inhibits Cas9 through interactions with the positively charged bridge helix, thereby preventing sgRNA loading. In vivo phage plaque assays and in vitro DNA cleavage assays show that AcrIIC2Nme mediates its activity through a large electronegative surface. This work shows that anti-CRISPR activity can be mediated through the inhibition of Cas9 complex assembly.
Mechanism of inhibition of CRISPR-Cas9 by anti-CRISPR protein AcrIIC1

Yalan Zhu,Sen Yin,Zhao Li

DOI: https://doi.org/10.1016/j.bbrc.2023.02.065

2023-04-30

Abstract:CRISPR-Cas (clustered regularly interspaced short palindromic repeats-CRISPR associated) systems are bacterial and archaeal defense mechanisms against invading phages and viruses. To overcome these defenses, phages and other mobile genetic elements (MGEs) have evolved multiple anti-CRISPR proteins (Acrs) that can inhibit the function of CRISPR-Cas systems. The AcrIIC1 protein has been shown to be able to inhibit the activity of Neisseria meningitidis Cas9 (NmeCas9) in both bacteria and human cells. Here, we solve the structure of AcrIIC1 in complex with the HNH domain of NmeCas9 using X-ray crystallography. The structure shows that AcrIIC1 binds to the catalytic sites of the HNH domain, preventing it from accessing the DNA target. In addition, our biochemical data show that AcrIIC1 is a broad-spectrum inhibitor targeting Cas9 enzymes from different subtypes. Taken together, the structure and biochemical analysis reveal the molecular mechanism of AcrIIC1-mediated Cas9 inhibition and provide new insights into regulatory tools for Cas9-based applications.
Mechanistic insights into the inhibition of the CRISPR-Cas surveillance complex by anti-CRISPR protein AcrIF13

Hao Wang,Teng Gao,Yu Zhou,Junhui Ren,Junhua Guo,Jianwei Zeng,Yu Xiao,Yi Zhang,Yue Feng

DOI: https://doi.org/10.1016/j.jbc.2022.101636

IF: 5.485

2022-03-01

Journal of Biological Chemistry

Abstract:Clustered regularly interspaced short palindromic repeats (CRISPRs) and CRISPR-associated (Cas) proteins provide prokaryotes with nucleic acid-based adaptive immunity against infections of mobile genetic elements, including phages. To counteract this immune process, phages have evolved various anti-CRISPR (Acr) proteins which deactivate CRISPR-Cas-based immunity. However, the mechanisms of many of these Acr-mediated inhibitions are not clear. Here, we report the crystal structure of AcrIF13 and explore its inhibition mechanism. The structure of AcrIF13 is unique and displays a negatively charged surface. Additionally, biochemical studies identified that AcrIF13 interacts with the type I-F CRISPR-Cas surveillance complex (Csy complex) to block target DNA recognition and that the Cas5f-8f tail and Cas7.6f subunit of the Csy complex are specific binding targets of AcrIF13. Further mutational studies demonstrated that several negatively charged residues of AcrIF13 and positively charged residues of Cas8f and Cas7f of the Csy complex are involved in AcrIF13-Csy binding. Together, our findings provide mechanistic insights into the inhibition mechanism of AcrIF13 and further suggest the prevalence of the function of Acr proteins as DNA mimics.

biochemistry & molecular biology
AcrIIC4 inhibits type II-C Cas9 by preventing R-loop formation

Wei Sun,Zhi Cheng,Jiuyu Wang,Jing Yang,Xueyan Li,Jinlong Wang,Minxuan Chen,Xiaoqi Yang,Gang Sheng,Jizhong Lou,Yanli Wang

DOI: https://doi.org/10.1073/pnas.2303675120

Abstract:Anti-CRISPR (Acr) proteins are encoded by phages and other mobile genetic elements and inhibit host CRISPR-Cas immunity using versatile strategies. AcrIIC4 is a broad-spectrum Acr that inhibits the type II-C CRISPR-Cas9 system in several species by an unknown mechanism. Here, we determined a series of structures of Haemophilus parainfluenzae Cas9 (HpaCas9)-sgRNA in complex with AcrIIC4 and/or target DNA, as well as the crystal structure of AcrIIC4 alone. We found that AcrIIC4 resides in the crevice between the REC1 and REC2 domains of HpaCas9, where its extensive interactions restrict the mobility of the REC2 domain and prevent the unwinding of target double-stranded (ds) DNA at the PAM-distal end. Therefore, the full-length guide RNA:target DNA heteroduplex fails to form in the presence of AcrIIC4, preventing Cas9 nuclease activation. Altogether, our structural and biochemical studies illuminate a unique Acr mechanism that allows DNA binding to the Cas9 effector complex but blocks its cleavage by preventing R-loop formation, a key step supporting DNA cleavage by Cas9.
Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type IIC Anti-CRISPR Proteins

Yalan Zhu,Ang Gao,Qi Zhan,Yong Wang,Han Feng,Songqing Liu,Guangxia Gao,Alexander Serganov,Pu Gao

DOI: https://doi.org/10.1016/j.molcel.2019.01.038

IF: 16

2019-04-01

Molecular Cell

Abstract:Anti-CRISPR proteins (Acrs) targeting CRISPR-Cas9 systems represent natural "off switches" for Cas9-based applications. Recently, AcrIIC1, AcrIIC2, and AcrIIC3 proteins were found to inhibit Neisseria meningitidis Cas9 (NmeCas9) activity in bacterial and human cells. Here we report biochemical and structural data that suggest molecular mechanisms of AcrIIC2- and AcrIIC3-mediated Cas9 inhibition. AcrIIC2 dimer interacts with the bridge helix of Cas9, interferes with RNA binding, and prevents DNA loading into Cas9. AcrIIC3 blocks the DNA loading step through binding to a non-conserved surface of the HNH domain of Cas9. AcrIIC3 also forms additional interactions with the REC lobe of Cas9 and induces the dimerization of the AcrIIC3-Cas9 complex. While AcrIIC2 targets Cas9 orthologs from different subtypes, albeit with different efficiency, AcrIIC3 specifically inhibits NmeCas9. Structure-guided changes in NmeCas9 orthologs convert them into anti-CRISPR-sensitive proteins. Our studies provide insights into anti-CRISPR-mediated suppression mechanisms and guidelines for designing regulatory tools in Cas9-based applications.

cell biology,biochemistry & molecular biology
Inhibition mechanisms of CRISPR-Cas9 by AcrIIA17 and AcrIIA18

Xiaoshen Wang,Xuzichao Li,Yongjian Ma,Jiaqi He,Xiang Liu,Guimei Yu,Hang Yin,Heng Zhang

DOI: https://doi.org/10.1093/nar/gkab1197

IF: 14.9

2021-12-10

Nucleic Acids Research

Abstract:Abstract Mobile genetic elements such as phages and plasmids have evolved anti-CRISPR proteins (Acrs) to suppress CRISPR-Cas adaptive immune systems. Recently, several phage and non-phage derived Acrs including AcrIIA17 and AcrIIA18 have been reported to inhibit Cas9 through modulation of sgRNA. Here, we show that AcrIIA17 and AcrIIA18 inactivate Cas9 through distinct mechanisms. AcrIIA17 inhibits Cas9 activity through interference with Cas9-sgRNA binary complex formation. In contrast, AcrIIA18 induces the truncation of sgRNA in a Cas9-dependent manner, generating a shortened sgRNA incapable of triggering Cas9 activity. The crystal structure of AcrIIA18, combined with mutagenesis studies, reveals a crucial role of the N-terminal β-hairpin in AcrIIA18 for sgRNA cleavage. The enzymatic inhibition mechanism of AcrIIA18 is different from those of the other reported type II Acrs. Our results add new insights into the mechanistic understanding of CRISPR-Cas9 inhibition by Acrs, and also provide valuable information in the designs of tools for conditional manipulation of CRISPR-Cas9.

biochemistry & molecular biology
Opiate blockade enhances hypoglycemic counterregulation in normal and insulin-dependent diabetic subjects.

S. Caprio,G. Gerety,W. Tamborlane,T. Jones,M. Diamond,R. Jacob,R. Sherwin

DOI: https://doi.org/10.1152/AJPENDO.1991.260.6.E852

1991-06-01

Abstract:To examine the impact of opiate blockade on glucose counterregulation we performed two hypoglycemic insulin clamp studies with and without naloxone in healthy subjects and well-controlled insulin-dependent (IDDM) patients with defective glucose counterregulation. During both studies plasma glucose fell to 55-60 mg/dl and was then maintained at that level using a variable glucose infusion. In normal subjects, naloxone increased glucose production, thereby reducing the exogenous glucose dose needed to maintain the hypoglycemic plateau. Epinephrine and cortisol responses to hypoglycemia were increased during naloxone plus insulin compared with insulin alone; glucagon responses were unaffected. IDDM patients with suppressed hepatic and hormonal responses to insulin-induced hypoglycemia also demonstrated greater stimulation of glucose production as well as epinephrine, growth hormone, and cortisol release during the naloxone study. In the absence of hypoglycemia, naloxone did not significantly affect glucose production or glucoregulatory hormones. We conclude that opiate blockade augments glucoregulatory responses to insulin-induced hypoglycemia, even in IDDM patients with preexisting defects in glucose counterregulation. This effect is at least in part due to enhanced counterregulatory hormone release during hypoglycemia. Endogenous opiates may modulate hormonal responses during hypoglycemia; their blockade could provide a means of ameliorating defective counterregulation in IDDM patients.
Structural and mechanistic insights into inhibition of the type I-F CRISPR-Cas surveillance complex by AcrIF4

Zhengyu Gao,Laixing Zhang,Zihao Ge,Hao Wang,Yourun Yue,Zhuobing Jiang,Xin Wang,Chenying Xu,Yi Zhang,Maojun Yang,Yue Feng

DOI: https://doi.org/10.1101/2022.08.30.504949

2022-01-01

Abstract:CRISPR-Cas system provides prokaryotes with protection against mobile genetic elements (MGEs) such as phages. In turn, phages deploy anti-CRISPR (Acr) proteins to evade this immunity. AcrIF4, an Acr targeting the type I-F CRISPR-Cas system, has been reported to bind the crRNA-guided surveillance (Csy) complex. However, it remains controversial whether AcrIF4 inhibits target DNA binding to the Csy complex. Here, we present structural and mechanistic studies into AcrIF4, exploring its unique anti-CRISPR mechanism. While the Csy-AcrIF4 complex displays decreased affinity for target DNA, it is still able to bind the DNA. Structural and functional analyses of the Csy-AcrIF4-dsDNA complex revealed that AcrIF4 binding prevents rotation of the helical bundle (HB) of Cas8f induced by dsDNA binding, therefore resulting in failure of Cas2/3 recruitment and DNA cleavage. Overall, our study provides an interesting example of attack on the nuclease recruitment event by an Acr, but not conventional mechanisms of blocking binding of target DNA. ### Competing Interest Statement The authors have declared no competing interest.
Evaluation of antifungal, insecticidal and phytotoxic activities of stem wood of Millettia ovalifolia

T. Rahman,K. Khattak,W. Liaqat

Abstract:In the current study, the stem wood of Millettia ovalifolia was evaluated for antifungal, insecticidal and phytotoxic activities. The results revealed that all the fractions showed no antibacterial activity against the tested bacterial strains. In case of antifungal activity, only ethyl acetate (EA) and chloroform (C) fractions exhibited minimum inhibitory concentration both at 500 µg/ml against Microsporum canis. The results of insecticidal activity reveled that ethyl acetate and chloroform fractions were effective against Tribolium castaneum, Rhyzopertha dominica and Callos bruchuanalis. The phytotoxicity data showed that all the fractions affected the growth of lemna minor at the concentration level of 500 µg/ml. The ethyl acetate (EA) and chloroform (C) fractions were found biologically active. These fractions should be further investigated for potential antifungal, insecticidal and phytotoxic compounds.
Anti-CRISPR Protein AcrIF4 Inhibits the Type I-F CRISPR-Cas Surveillance Complex by Blocking Nuclease Recruitment and DNA Cleavage

Zhengyu Gao,Laixing Zhang,Zihao Ge,Hao Wang,Yourun Yue,Zhuobing Jiang,Xin Wang,Chenying Xu,Yi Zhang,Maojun Yang,Yue Feng

DOI: https://doi.org/10.1016/j.jbc.2022.102575

IF: 5.485

2022-01-01

Journal of Biological Chemistry

Abstract:The clustered regularly interspaced short palindromic repeats (CRISPR)-Cas system provides prokaryotes with protection against mobile genetic elements such as phages. In turn, phages deploy anti-CRISPR (Acr) proteins to evade this immunity. AcrIF4, an Acr targeting the type I-F CRISPR-Cas system, has been reported to bind the crRNA-guided surveillance (Csy) complex. However, it remains controversial whether AcrIF4 inhibits target DNA binding to the Csy complex. Here, we present structural and mechanistic studies into AcrIF4, exploring its unique anti-CRISPR mechanism. While the Csy-AcrIF4 complex displays decreased affinity for target DNA, it is still able to bind the DNA. Our structural and functional analyses of the Csy-AcrIF4-dsDNA complex revealed that AcrIF4 binding prevents rotation of the helical bundle of the Cas8f subunit induced by dsDNA binding, therefore resulting in failure of nuclease Cas2/3 recruitment and DNA cleavage. Overall, our study provides an interesting example of attack on the nuclease recruitment event by an Acr, but not conventional mechanisms of blocking binding of target DNA.
Structural insight into multistage inhibition of CRISPR-Cas12a by AcrVA4

Ruchao Peng,Zhiteng Li,Ying Xu,Shaoshuai He,Qi Peng,Lian-Ao Wu,Ying Wu,Jianxun Qi,Peiyi Wang,Yi Shi,George F Gao,Lian-ao Wu,George F. Gao

DOI: https://doi.org/10.1073/pnas.1909400116

IF: 11.1

2019-08-29

Proceedings of the National Academy of Sciences

Abstract:Significance Bacteriophage encodes anti-CRISPR (Acr) proteins to inactivate host bacterial CRISPR-Cas systems. These Acrs are also found in bacteria to avoid self-targeting autoimmunity. So far, quite a few Acrs targeting type I and II CRISPR-Cas systems have been well characterized. In contrast, the Acrs inhibiting type V systems remain poorly understood. Both type II (Cas9) and V (Cas12a) CRISPR-Cas systems have been harnessed as powerful tools for genome editing and the latter showed even better efficiency and accuracy. In this work, we report a comprehensive mechanistic insight into a unique multistage inhibitor, AcrVA4, blocking CRISPR-Cas12a activity, different from other characterized single-stage targeting Acrs. This represents a sophisticated mechanism for CRISPR-Cas inhibition and provides clues for developing regulatory tools for genome editing.

multidisciplinary sciences
The novel anti-CRISPR AcrIIA22 relieves DNA torsion in target plasmids and impairs SpyCas9 activity

Kevin J Forsberg,Danica T Schmidtke,Rachel Werther,Ruben V Uribe,Deanna Hausman,Morten O A Sommer,Barry L Stoddard,Brett K Kaiser,Harmit S Malik

DOI: https://doi.org/10.1371/journal.pbio.3001428

2021-10-13

Abstract:To overcome CRISPR-Cas defense systems, many phages and mobile genetic elements (MGEs) encode CRISPR-Cas inhibitors called anti-CRISPRs (Acrs). Nearly all characterized Acrs directly bind Cas proteins to inactivate CRISPR immunity. Here, using functional metagenomic selection, we describe AcrIIA22, an unconventional Acr found in hypervariable genomic regions of clostridial bacteria and their prophages from human gut microbiomes. AcrIIA22 does not bind strongly to SpyCas9 but nonetheless potently inhibits its activity against plasmids. To gain insight into its mechanism, we obtained an X-ray crystal structure of AcrIIA22, which revealed homology to PC4-like nucleic acid-binding proteins. Based on mutational analyses and functional assays, we deduced that acrIIA22 encodes a DNA nickase that relieves torsional stress in supercoiled plasmids. This may render them less susceptible to SpyCas9, which uses free energy from negative supercoils to form stable R-loops. Modifying DNA topology may provide an additional route to CRISPR-Cas resistance in phages and MGEs.
Atomic-scale insights into allosteric inhibition and evolutional rescue mechanism of Streptococcus thermophilus Cas9 by the anti-CRISPR protein AcrIIA6

Xinyi Li,Chengxiang Wang,Ting Peng,Zongtao Chai,Duan Ni,Yaqin Liu,Jian Zhang,Ting Chen,Shaoyong Lu

DOI: https://doi.org/10.1016/j.csbj.2021.11.010

IF: 6.155

2021-01-01

Computational and Structural Biotechnology Journal

Abstract:CRISPR-Cas systems are prokaryotic adaptive immunity against invading phages and plasmids. Phages have evolved diverse protein inhibitors of CRISPR-Cas systems, called anti-CRISPR (Acr) proteins, to neutralize this CRISPR machinery. In response, bacteria have co-evolved Cas variants to escape phage's anti-CRISPR strategies, called anti-anti-CRISPR systems. Here we explore the anti-CRISPR allosteric inhibition and anti-anti-CRISPR rescue mechanisms between <i>Streptococcus thermophilus</i> Cas9 (St1Cas9) and the anti-CRISPR protein AcrIIA6 at the atomic level, by generating mutants of key residues in St1Cas9. Extensive unbiased molecular dynamics simulations show that the functional motions of St1Cas9 in the presence of AcrIIA6 differ substantially from those of St1Cas9 alone. AcrIIA6 binding triggers a shift of St1Cas9 conformational ensemble towards a less catalytically competent state; this state significantly compromises protospacer adjacent motif (PAM) recognition and nuclease activity by altering interdependently conformational dynamics and allosteric signals among nuclease domains, PAM-interacting (PI) regions, and AcrIIA6 binding motifs. Via <i>in vitro</i> DNA cleavage assays, we further elucidate the rescue mechanism of efficiently escaping AcrIIA6 inhibition harboring St1Cas9 triple mutations (G993K/K1008M/K1010E) in the PI domain and identify the evolutionary landscape of such mutational escape within species. Our results provide mechanistic insights into Acr proteins as natural brakes for the CRISPR-Cas systems and a promising potential for the design of allosteric Acr peptidomimetics.

biochemistry & molecular biology
Insights into the Dual Functions of AcrIF14 During the Inhibition of Type I-F CRISPR–Cas Surveillance Complex

Xi Liu,Laixing Zhang,Yu Xiu,Teng Gao,Ling Huang,Yongchao Xie,Lingguang Yang,Wenhe Wang,Peiyi Wang,Yi Zhang,Maojun Yang,Yue Feng

DOI: https://doi.org/10.1093/nar/gkab738

IF: 14.9

2021-01-01

Nucleic Acids Research

Abstract:CRISPR-Cas systems are bacterial adaptive immune systems, and phages counteract these systems using many approaches such as producing anti-CRISPR (Acr) proteins. Here, we report the structures of both AcrIF14 and its complex with the crRNA-guided surveillance (Csy) complex. Our study demonstrates that apart from interacting with the Csy complex to block the hybridization of target DNA to the crRNA, AcrIF14 also endows the Csy complex with the ability to interact with non-sequence-specific dsDNA as AcrIF9 does. Further structural studies of the Csy-AcrIF14-dsDNA complex and biochemical studies uncover that the PAM recognition loop of the Cas8f subunit of the Csy complex and electropositive patches within the N-terminal domain of AcrIF14 are essential for the non-sequence-specific dsDNA binding to the Csy-AcrIF14 complex, which is different from the mechanism of AcrIF9. Our findings highlight the prevalence of Acr-induced non-specific DNA binding and shed light on future studies into the mechanisms of such Acr proteins.
Structural and biochemical insights into the mechanism of the anti-CRISPR protein AcrIE3

Jasung Koo,Gyujin Lee,Changkon Park,Hyejin Oh,Sung-Hyun Hong,Jeong-Yong Suh,Euiyoung Bae

DOI: https://doi.org/10.1016/j.str.2024.10.024

IF: 5.871

2024-11-20

Structure

Abstract:Summary Anti-CRISPR (Acr) proteins are natural inhibitors of CRISPR-Cas systems, found in bacteriophages and other genetic elements. AcrIE3, identified in a Pseudomonas phage, inactivates the type I-E CRISPR-Cas system in Pseudomonas aeruginosa by engaging with the Cascade complex. However, its precise inhibition mechanism has remained elusive. In this study, we present a comprehensive structural and biochemical analysis of AcrIE3, providing mechanistic insight into its anti-CRISPR function. Our results reveal that AcrIE3 selectively binds to the Cas8e subunit of the Cascade complex. The crystal structure of AcrIE3 exhibits an all-helical fold with a negatively charged surface. Through extensive mutational analyses, we show that AcrIE3 interacts with the protospacer adjacent motif (PAM) recognition site in Cas8e through its negatively charged surface residues. These findings enhance our understanding of the structure and function of type I-E Acr proteins, suggesting PAM interaction sites as primary targets for divergent Acr inhibitors.

cell biology,biochemistry & molecular biology,biophysics

Integrating Procurement, Production Planning, and Inventory Management Processes through Negotiation Information

Inhibition mechanisms of CRISPR-Cas9 by AcrIIA25.1 and AcrIIA32

Disabling Cas9 by an anti-CRISPR DNA mimic

Anti-CRISPR AcrIIC5 is a dsDNA mimic that inhibits type II-C Cas9 effectors by blocking PAM recognition

Structural and Mechanistic Insight into CRISPR-Cas9 Inhibition by Anti-CRISPR Protein AcrIIC4Hpa

Inhibitory mechanism of CRISPR-Cas9 by AcrIIC4

Inhibition of CRISPR-Cas9 ribonucleoprotein complex assembly by anti-CRISPR AcrIIC2

Mechanism of inhibition of CRISPR-Cas9 by anti-CRISPR protein AcrIIC1

Mechanistic insights into the inhibition of the CRISPR-Cas surveillance complex by anti-CRISPR protein AcrIF13

AcrIIC4 inhibits type II-C Cas9 by preventing R-loop formation

Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type IIC Anti-CRISPR Proteins

Inhibition mechanisms of CRISPR-Cas9 by AcrIIA17 and AcrIIA18

Opiate blockade enhances hypoglycemic counterregulation in normal and insulin-dependent diabetic subjects.

Structural and mechanistic insights into inhibition of the type I-F CRISPR-Cas surveillance complex by AcrIF4

Evaluation of antifungal, insecticidal and phytotoxic activities of stem wood of Millettia ovalifolia

Anti-CRISPR Protein AcrIF4 Inhibits the Type I-F CRISPR-Cas Surveillance Complex by Blocking Nuclease Recruitment and DNA Cleavage

Structural insight into multistage inhibition of CRISPR-Cas12a by AcrVA4

The novel anti-CRISPR AcrIIA22 relieves DNA torsion in target plasmids and impairs SpyCas9 activity

Atomic-scale insights into allosteric inhibition and evolutional rescue mechanism of Streptococcus thermophilus Cas9 by the anti-CRISPR protein AcrIIA6

Insights into the Dual Functions of AcrIF14 During the Inhibition of Type I-F CRISPR–Cas Surveillance Complex

Structural and biochemical insights into the mechanism of the anti-CRISPR protein AcrIE3